Document ID: chunk:federal_register_of_legislation:F2020L01649:clause:1_4
Version: federal_register_of_legislation:F2020L01649
Segment Type: clause
Provision Reference: sch 1 cl 4
Character Range: 1529–2504

4  Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) indications;
(b) medicine;
(c) passed preliminary assessment;
(d) registered goods;
(e) Secretary; and
(f) therapeutic goods.
  In this instrument:
Act means the Therapeutic Goods Act 1989.
new indications medicine has the same meaning as in the Regulations.
new prescription medicine has the same meaning as in the Regulations.
registered medicine means a medicine that is a registered good.
Regulations means the Therapeutic Goods Regulations 1990.
relevant medicine means a new prescription medicine or a new indications medicine, which is the subject of an application for registration under section 23 of the Act that has passed preliminary assessment, but does not include a medicine that is a biosimilar in relation to a registered medicine.
therapeutic goods information has the meaning given by subsection 61(1) of the Act.